Acurácia da core biopsy estereotática no diagnóstico de carcinoma e invasäo estromal em lesöes mamárias impalpáveis

Lima, Mara do Carmo Abreu e; Maranhäo, Norma; Costa, Isis; Bulhöes, Tatiana Aguiar; Lima, Manuela Abreu e.
Rev. bras. mastologia ; 8(2): 76-80, jun. 1998. ilus, tab
Artículo en Portugués | LILACS | ID: lil-214531

Documentos relacionados

  1. Archival single-cell genomics reveals persistent subclones during DCIS progression.
  2. The role of mineralocorticoids and glucocorticoids under the impact of 11ß-hydroxysteroid dehydrogenase in human breast lesions.
  3. Updates on treating ductal carcinoma in situ: what's to know in 2021.
  4. Deep-learning model to improve histological grading and predict upstaging of atypical ductal hyperplasia / ductal carcinoma in situ on breast biopsy.
  5. Prognostic significance of microinvasion with ductal carcinoma in situ of the breast: a meta-analysis.
  6. Pathologic complete response of ductal carcinoma in situ to neoadjuvant systemic therapy in HER2-positive invasive breast cancer patients: a nationwide analysis.
  7. Stromal Changes are Associated with High P4HA2 Expression in Ductal Carcinoma in Situ of the Breast.
  8. Tumor Characteristics of Bilateral Breast Cancer Compared with Unilateral Breast Cancer.
  9. Immune cell infiltrate in ductal carcinoma in situ and the risk of dying from breast cancer: case-control study.
  10. [The value of immunohistochemical expression of Ki-67 and CD34 in differentiating ductal carcinoma in situ from ductal carcinoma in situ-like invasive breast cancer].